Inventor · disambiguated record
Kathryn Oliver
Also filed as: OLIVER KATHRYN
10 granted patents·2 pending applications·24 citations·filing 2009–2021
87Inventor score
Files withPROXIMAGEN LTD4PROXIMAGEN LLC3BENEVOLENTAI CAMBRIDGE LTD2SAVORY EDWARD DANIEL2SAVORY EDWARD1
Top patents by PatentIndex Score
12 records- 0188US10995091B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2018·Granted May 4, 2021·3 cites·14 claims
- 0285US10155761B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2017·Granted Dec 18, 2018·4 cites·16 claims
- 0383US9353086B2CXCR4 receptor antagonistsSAVORY EDWARD DANIEL·Filed 2011·Granted May 31, 2016·6 cites·17 claims
- 0483US8263616B24,5,6,7-tetrahydroimidazo[4,5-c]pyridine compoundsSAVORY EDWARD DANIEL·Filed 2009·Granted Sep 11, 2012·5 cites·7 claims
- 0580US9493457B24,5,6,7-tetrahyroimidazo[4,5-c]pyridine compoundsPROXIMAGEN LTD·Filed 2015·Granted Nov 15, 2016·2 cites·8 claims
- 0676US9890160B2Compounds IPROXIMAGEN LTD·Filed 2016·Granted Feb 13, 2018·1 cites·16 claims
- 0773US9035066B2Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compoundsPROXIMAGEN LTD·Filed 2013·Granted May 19, 2015·1 cites·20 claims
- 0872US8569338B2Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compoundsSAVORY EDWARD·Filed 2012·Granted Oct 29, 2013·2 cites·15 claims
- 0972US2022348577A1CXCR4 Receptor AntagonistsPROXIMAGEN LLC·Filed 2021·Application pending·0 cites
- 1067US11040969B2Compounds IBENEVOLENTAI CAMBRIDGE LTD·Filed 2019·Granted Jun 22, 2021·0 cites·6 claims
- 1163US10399973B2Compounds IBENEVOLENTAI CAMBRIDGE LTD·Filed 2017·Granted Sep 3, 2019·0 cites·12 claims
- 1253US2016046606A1CXCR4 Receptor AntagonistsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathryn Oliver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →